Real-time Estimate Cboe Europe 04:58:26 2024-05-10 am EDT 5-day change 1st Jan Change
73.41 CHF +0.64% Intraday chart for Alcon Inc. +1.91% +12.04%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
Sales 2024 * 10B 9.07B Sales 2025 * 10.65B 9.65B Capitalization 39.61B 35.91B
Net income 2024 * 936M 848M Net income 2025 * 1.26B 1.14B EV / Sales 2024 * 4.25 x
Net Debt 2024 * 2.95B 2.67B Net Debt 2025 * 1.76B 1.59B EV / Sales 2025 * 3.88 x
P/E ratio 2024 *
44.1 x
P/E ratio 2025 *
34 x
Employees 25,315
Yield 2024 *
0.36%
Yield 2025 *
0.43%
Free-Float 98.58%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.52%
1 week+2.44%
Current month+2.59%
1 month-2.88%
3 months+8.44%
6 months+9.98%
Current year+11.12%
More quotes
1 week
71.60
Extreme 71.6
73.70
1 month
70.90
Extreme 70.9
75.56
Current year
62.24
Extreme 62.24
77.60
1 year
61.28
Extreme 61.28
77.60
3 years
55.22
Extreme 55.22
81.40
5 years
38.63
Extreme 38.625
81.40
10 years
38.63
Extreme 38.625
81.40
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 16-06-30
Director of Finance/CFO 56 19-04-07
Chief Tech/Sci/R&D Officer - 11-05-31
Members of the board TitleAgeSince
Chairman 68 18-06-30
Director/Board Member 65 18-12-31
Director/Board Member 60 19-01-31
More insiders
Date Price Change Volume
24-05-10 73.52 +0.80% 156 060
24-05-08 72.94 -0.52% 715,324
24-05-07 73.32 +1.13% 794,861
24-05-06 72.5 +0.47% 588,273
24-05-03 72.16 +1.35% 615,271

Delayed Quote Swiss Exchange, May 08, 2024 at 11:31 am EDT

More quotes
Alcon Inc. is the global leader in the design, manufacture and marketing of ophthalmic care products. Net sales break down by category of products as follows: - ophthalmic surgical products and equipment (56.7%): consumables (51.2% of net sales), implantable products (32%) and other products (16.8%; in particular surgical equipment) for the treatment of cataracts, retinal diseases, glaucoma and refractive errors; - vision care products (43.3%): contact lenses (59.2% of sales) and eye care products (40.8%; eye drops and ophthalmic ointments, etc.) At the end of 2023, the group operated 19 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (0.7%), the United States (46%), Japan (6.2%), China (5.6%) and other (41,5%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
80.31 USD
Average target price
93.1 USD
Spread / Average Target
+15.92%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW